Tirzepatide
Weight & Glucose Manager.
Scientific Overview
A once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
Key Research Benefits
- ✓Weight loss
- ✓Appetite suppression
- ✓Blood sugar control
Potential Side Effects
Research Protocols
Common DosagesMetabolic Titration
“Start at 2.5mg for 4 weeks; titrate up as needed”
Dose Calculator
🧮 Peptide Reconstitution Calculator
Total amount of peptide in the vial.
Volume of water used to mix.
Draw to this mark
or 0.10 mL on a U-100 syringe
Explore Tirzepatide
Quick Explainer
Stack Tirzepatide with…
Curated stacking partners researched alongside Tirzepatide. Each link opens a dedicated stack page with combined benefits, side-effect overlap, and half-life considerations.
Tirzepatide by goal
Read Tirzepatide's profile filtered through specific research goals.
Molecular Profile
Quick Reference
- Status
- Research Compound
- Category
- Metabolic
- Common Dosage
- 2.5 mg -> 15 mg
- Weekly
- Plasma decay
t½ 5.0 d · ~3% remaining at 25 d
Strictly for research purposes. Not for human consumption.
Related tools
Medical Disclaimer
Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.